Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kirk Barber

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Journal of Cutaneous Medicine and Surgery|May 1, 2015
Non-melanoma Skin Cancer in Canada Chapter 3: Management of Actinic KeratosesYves Poulin, Charles W Lynde, Kirk Barber, et al.
Journal of Cutaneous Medicine and Surgery|May 9, 2015
Long-term Management of Moderate to Severe Plaque Psoriasis Patients With Etanercept: A Case SeriesMarc Bourcier, Kim Alexander Papp, Wayne P Gulliver, et al.
Journal of Cutaneous Medicine and Surgery|October 16, 2009
Canadian practical guide for the treatment and management of atopic dermatitisCharles Lynde, Kirk Barber, Joel Claveau, et al.
Journal of Cutaneous Medicine and Surgery|January 19, 2005
Incorporating biologics into the treatment of psoriasisHarvey Lui, Richard Langley, Yves Poulin, et al.
Journal of Cutaneous Medicine and Surgery|November 19, 2010
Canadian hand dermatitis management guidelinesCharles Lynde, Lyn Guenther, Thomas L Diepgen, et al.
Journal of Cutaneous Medicine and Surgery|March 26, 2009
ISA247: quality of life results from a phase II, randomized, placebo-controlled studyAditya K Gupta, Richard G Langley, Charles Lynde, et al.
Journal of Cutaneous Medicine and Surgery|September 15, 2017
An Open Letter to Health CanadaKim Papp, Lorne Albrecht, Kirk Barber, et al.
Journal of Cutaneous Medicine and Surgery|April 14, 2017
Structured Expert Consensus on Actinic Keratosis: Treatment Algorithm Focusing on Daylight PDTPiergiacomo Calzavara-Pinton, Merete Hædersdal, Kirk Barber, et al.
JAMA Dermatology|October 13, 2021
Effect of Costimulatory Blockade With Abatacept After Ustekinumab Withdrawal in Patients With Moderate to Severe Plaque Psoriasis: The PAUSE Randomized Clinical TrialKristina M Harris, Dawn E Smilek, Margie Byron, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 13, 2025
Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open-label extension studyMatthias Augustin, Marie Tauber, Robert Sidbury, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Journal of Cutaneous Medicine and Surgery|May 1, 2015
Non-melanoma Skin Cancer in Canada Chapter 3: Management of Actinic KeratosesYves Poulin, Charles W Lynde, Kirk Barber, et al.
Journal of Cutaneous Medicine and Surgery|May 9, 2015
Long-term Management of Moderate to Severe Plaque Psoriasis Patients With Etanercept: A Case SeriesMarc Bourcier, Kim Alexander Papp, Wayne P Gulliver, et al.
Journal of Cutaneous Medicine and Surgery|October 16, 2009
Canadian practical guide for the treatment and management of atopic dermatitisCharles Lynde, Kirk Barber, Joel Claveau, et al.
Journal of Cutaneous Medicine and Surgery|January 19, 2005
Incorporating biologics into the treatment of psoriasisHarvey Lui, Richard Langley, Yves Poulin, et al.
Journal of Cutaneous Medicine and Surgery|November 19, 2010
Canadian hand dermatitis management guidelinesCharles Lynde, Lyn Guenther, Thomas L Diepgen, et al.
Journal of Cutaneous Medicine and Surgery|March 26, 2009
ISA247: quality of life results from a phase II, randomized, placebo-controlled studyAditya K Gupta, Richard G Langley, Charles Lynde, et al.
Journal of Cutaneous Medicine and Surgery|September 15, 2017
An Open Letter to Health CanadaKim Papp, Lorne Albrecht, Kirk Barber, et al.
Journal of Cutaneous Medicine and Surgery|April 14, 2017
Structured Expert Consensus on Actinic Keratosis: Treatment Algorithm Focusing on Daylight PDTPiergiacomo Calzavara-Pinton, Merete Hædersdal, Kirk Barber, et al.
JAMA Dermatology|October 13, 2021
Effect of Costimulatory Blockade With Abatacept After Ustekinumab Withdrawal in Patients With Moderate to Severe Plaque Psoriasis: The PAUSE Randomized Clinical TrialKristina M Harris, Dawn E Smilek, Margie Byron, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 13, 2025
Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open-label extension studyMatthias Augustin, Marie Tauber, Robert Sidbury, et al.
Pageof 9